MediWound Ltd. (MDWD)
12.87
-0.28
(-2.13%)
USD |
NASDAQ |
Oct 07, 16:00
12.87
0.00 (0.00%)
After-Hours: 20:00
MediWound EPS Diluted (Quarterly) : -0.5737 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5737 |
| March 31, 2026 | -0.2293 |
| December 31, 2025 | -0.5601 |
| September 30, 2025 | -0.2406 |
| June 30, 2025 | -1.229 |
| March 31, 2025 | -0.0672 |
| December 31, 2024 | -0.3622 |
| September 30, 2024 | -0.9782 |
| June 30, 2024 | -0.6795 |
| March 31, 2024 | -1.054 |
| December 31, 2023 | -0.189 |
| September 30, 2023 | -0.2383 |
| June 30, 2023 | 0.0995 |
| March 31, 2023 | -0.4403 |
| December 31, 2022 | -1.178 |
| September 30, 2022 | -0.8779 |
| June 30, 2022 | -0.9197 |
| March 31, 2022 | -0.8744 |
| December 31, 2021 | -1.069 |
| September 30, 2021 | -0.8595 |
| June 30, 2021 | -0.8219 |
| March 31, 2021 | -0.7327 |
| December 31, 2020 | -0.4456 |
| September 30, 2020 | -0.4911 |
| June 30, 2020 | -0.7965 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.6331 |
| December 31, 2019 | -0.8868 |
| September 30, 2019 | -0.0536 |
| June 30, 2019 | 3.275 |
| March 31, 2019 | -1.058 |
| December 31, 2018 | 2.731 |
| September 30, 2018 | -0.7582 |
| June 30, 2018 | -1.05 |
| March 31, 2018 | -1.19 |
| December 31, 2017 | -0.63 |
| September 30, 2017 | -3.43 |
| June 30, 2017 | -1.40 |
| March 31, 2017 | -1.40 |
| December 31, 2016 | -0.63 |
| September 30, 2016 | -1.82 |
| June 30, 2016 | -2.38 |
| March 31, 2016 | -1.19 |
| December 31, 2015 | -2.52 |
| September 30, 2015 | -1.19 |
| June 30, 2015 | -1.33 |
| March 31, 2015 | -2.10 |
| December 31, 2014 | -2.31 |
| September 30, 2014 | -1.68 |
| June 30, 2014 | -1.96 |
| March 31, 2014 | -0.35 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | -0.5029 |
| RedHill Biopharma Ltd. | -- |
| Purple Biotech Ltd. | 0.4069 |
| Sol-Gel Technologies Ltd. | -1.126 |
| PolyPid Ltd. | -0.3467 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.392M |
| Revenue (Quarterly) | 3.092M |
| Total Expenses (Quarterly) | 10.48M |
| Enterprise Value | 143.97M |
| Gross Profit Margin (Quarterly) | 10.90% |
| Profit Margin (Quarterly) | -239.1% |
| Earnings Yield | -12.46% |
| Normalized Earnings Yield | -12.46 |